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Abstract
Background: Ischemic stroke is the main cause of mortality and disability in older people worldwide. Recently
epidemiological studies indicate that ischemic stroke is a complex disorder with a strong genetic component.
Genome-wide association studies (GWAS) identified several single nucleotide polymorphisms (SNPs) associated
with coronary artery disease (CAD) and myocardial infarction (MI) locus in ABO gene. Our study examined the
association between four variants in the ABO gene and the risk of ischemic stroke and its subtypes, large-artery
atherosclerosis (LAA) and small-vessel diseases (SVD) in the Chinese population.
Methods: In this case–control study, we recruited 1897 subjects, including 979 healthy controls and 918 ischemic
stroke patients (465 with LAA and 453 with SVD). We selected four single nucleotide polymorphisms (rs579459,
rs651007, rs514659 and rs529565) of the ABO gene and performed genotyping assays to assess the association with
ischemic stroke and its subtypes.
Results: We found three polymorphisms, rs579459 and rs651007 were significantly associated with LAA using additive
model and rs529565 was significantly associated with LAA using additive and dominant models. And we failed to find
any significant association between these SNPs and ischemic stroke and SVD in the Chinese population. However, after
the Bonferroni correction for multiple comparisons, the P-values of these SNPs failed to exceed significant threshold
under any models.
Conclusion: Our findings indicated that genetic variations of ABO gene may contribute to susceptibility of LAA but not
ischemic stroke and SVD in the Chinese population. Our preliminary results should be further validated in prospective
independent studies with expanded sample size.
Keywords: Ischemic stroke, ABO, Single nucleotide polymorphism, Association study
Abbreviations: SNP, Single nucleotide polymorphism; GWAS, Genome-wide association studies; CAD, Coronary artery
disease; MI, Myocardial infarction; LAA, Large-artery atherosclerosis; SVD, Small-vessel diseases; VTE, Venous
thromboembolism; CT, Computed tomography; MRI, Magnetic resonance imaging; LD, Linkage disequilibrium;
HWE, Hardy-Weinberg equilibrium tests; OR, Odds ratio; CI, Confidence interval
Background
Stroke is one of the main causes of death and adult
disability around the world [1, 2]. There are two major
categories of stroke: ischemic stroke and hemorrhagic
stroke, and ischemic stroke constitutes over 80 % of total
stroke in origin [3]. Increasing evidence indicated that
ischemic stroke is a complex clinical syndrome resulting
from environmental and genetic factors [4, 5]. According
to the modified Trial of Org10172 in Acute Stroke
Treatment (TOAST) classification,ischemic stroke itself
can be divided into five subtypes, LAA and SVD are two
common etiologic subtypes of ischemic stroke [6, 7].
Conventional risk factors such as hypertension, diabetes
mellitus, dyslipidemia and smoking could not completely
explain all ischemic stroke risk, family and twin-based
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studies demonstrated that genetic factors also play a key
role in the development of ischemic stroke [8, 9].
The ABO gene, located around 9q34.2, encodes glyco-
syltransferases, which catalyze the transfer to different
carbohydrate groups onto the H antigen, thus forming A
and B antigens of the ABO system [10, 11]. In recent
years, several studies have found that genetic variants of
ABO gene were associated with several diseases. Previ-
ous studies have identified rs579459 in ABO as genetic
variants associated with the risk of CAD in European
descent [12]. Recent study also identified the ABO
rs579459 polymorphism as genetic variants significantly
associated with venous thromboembolism (VTE) [13].
However, fewer studies focus on the association between
ABO gene and ischemic stroke [14–16]. Ischemic stroke
and CAD have several common risk factors and genetic
susceptibility, especially for LAA and CAD. Taking all
these considerations together, the ABO gene may be a
promising candidate gene of ischemic stroke. Recent
GWAS showed that three SNPs (rs505922, rs643434,
and rs651007) of ABO gene were associated with ische-
mic stroke and its subtypes in the European population
[15]. However, there were no independent replication
studies regarding the association between ABO gene and
ischemic stroke in Chinese population.
Against this background, in the present study we
aimed to investigate the association between four SNPs
(rs579459, rs651007, rs514659 and rs529565) of ABO




Our study sample recruited 979 healthy controls and
918 ischemic stroke patients, including 465 with
LAA and 453 with SVD who presented consecutively
to the Second People’s Hospital Affiliated to Fujian
University of Traditional Chinese Medicine, Fujian
Provincial Hospital, Fuzhou General Hospital of
Nanjing Military Command and Fujian University of
Traditional Chinese Medicine Subsidiary Rehabilita-
tion Hospital during August 2013 to December 2014.
The Second People’s Hospital Affiliated to Fujian
University of Traditional Chinese Medicine as a
leader of the organization jointed three other
hospitals to collect the object of study. All case and
control subjects were unrelated to one another and
were recruited from the Chinese population. Clinical
diagnoses of ischemic stroke were confirmed through
computed tomography (CT) and/or magnetic reson-
ance imaging (MRI) scans of the brain. The brain
images were independently assessed by two well-
trained technologist and physician. The common
subtypes (LAA and SVD) of ischemic stroke were
determined by the modified TOAST classification
system [6]. Control subjects were recruited from the
health management of the Second People’s Hospital
Affiliated to Fujian University of Traditional Chinese
Medicine. Controls with stroke and other neuro-
logical diseases and cardiovascular diseases were
excluded in this study. The questionnaire was
designed to collect demographic characteristics, clin-
ical vascular variables, and medical histories for both
cases and controls. Conventional vascular risk factors
including hypertension, diabetes mellitus, and dyslip-
idemia were evaluated through WHO/ISH criteria.
This study was approved by the institutional review
boards of all participating hospitals. Written
informed consent and peripheral blood samples were
obtained from patients and controls before they
attended our study.
SNP selection and genotyping
We selected four SNPs of the ABO gene, including
rs579459, rs651007, rs643434, and rs505922. For two
SNPs, rs643434 and rs505922 failed assay primer
design, alternative SNPs in complete Linkage
disequilibrium (LD) were chosen. By HapMap,
rs643434 and rs505922 were replaced respectively
with rs514659 and rs529565 as in strong LD (r2 = 1)
in the Chinese population. The SNPs were genotyped
using Sequenom MassARRAY platform (San Diego,
U.S) at CapitalBio Corporation (Beijing, China) and
the genotyping analysis was undertaken according to
the manufacturer’s protocol.
Genomic DNA was isolated from human peripheral
blood samples of each individual through Wizard®
Genomic DNA Purification Kit (Promega, Madison, WI,
USA). DNA concentration was determined by DNA
spectrophotometer (ND-1000, NanoDrop, Wilmington
USA). Specific assays including a locus-specific PCR reac-
tion based on a locus-specific primer extension reaction
were designed using the MassARRAY Assay Design soft-
ware package (v3.1). Mass determination was carried out
with the MALDI-TOF mass spectrometer and Mass
ARRAY Type 4.0 software was used for data acquisition.
Data analysis
Association analysis was performed with PLINK soft-
ware using additive, dominant, recessive and genotype
models [17]. Hardy-Weinberg equilibrium (HWE) were
performed for each SNP. Logistic regression was used
for risk stratification with or without covariate adjust-
ments determined by significant differences between
ischemic stroke patients and controls, such as age,
gender, hypertension, and diabetes mellitus.
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Results
Clinical characteristics of total ischemic stroke patients
and controls
The demographic characteristics and clinical vascular
variables for the 918 ischemic stroke patients (51 %
LAA and 49 % SVD) and 979 healthy control subjects
used in this study are shown in Table 1. Distribution
of age and gender between cases and controls were
significantly different. Other risk factors such as
smoking, drinking, and diabetes mellitus were found
to be more prevalent in cases compared to controls.
Hypertension was significantly lower in ischemic
stroke cases than in controls. There were no signifi-
cant differences in levels of triglyceride between the
ischemic stroke cases and the controls, but total chol-
esterol, low density lipoprotein, and high density
lipoprotein levels were significantly lower in ischemic
stroke cases compared to controls.
Comparison of allele and genotype frequencies in
ischemic stroke
The association between the four SNPs in ABO gene and
the risk of ischemic stroke was analyzed using additive,
dominant, genotype, and recessive models. However, the
polymorphism rs514659 was not found to be in HWE in
control subjects, therefore excluded from further statis-
tical analyses. The observed allele and genotype frequen-
cies for ischemic stroke cases and controls are shown in
Table 2, rs579459 was significantly associated with the risk
of ischemic stroke using dominant model (p = 0.04, OR =
1.22, 95 % CI = 1.00-1.48). The allele frequencies of the
other two SNPs (rs651007 and rs529565) showed no
difference between the ischemic stroke and the control
group (p > 0.5). However, the association between
rs579459 and ischemic stroke failed to remain significance
after logistic regression analysis adjusting for age, gender,
hypertension, diabetes mellitus, dyslipidemia, smoking
and drinking status.
Comparison of allele and genotype frequencies in LAA
As shown in Table 3, we also observed the association
between the three SNPs of ABO gene and LAA occur-
rence under additive, dominant, genotype, and recessive
models. Three polymorphisms, rs579459, rs651007, and
rs529565 were significantly associated with LAA in both
additive and dominant models. After adjusting for age,
gender, hypertension, diabetes mellitus, and dyslipidemia
by logistic regression analysis, two polymorphisms,
rs579459 and rs651007 were remained significantly asso-
ciation with LAA using additive model and rs529565
was significantly associated with LAA using additive and
dominant models. However, all P-values failed to reach





Large Vessel Disease, n (%) 465 (51 %) /
Small Vessel Disease, n (%) 453 (49 %)
Age, years 69.39 ± 10.45* 67.04 ± 10.26
Male, n (%) 601 (65 %)* 562 (57 %)
Female, n (%) 317 (35 %)* 417 (43 %)
Hypertension, n (%) 216 (24 %)* 316 (32 %)
Diabetes, n (%) 598 (65 %)* 126 (13 %)
Smoking, n (%) 626 (68 %)* 170 (17 %)
Drinking, n (%) 736 (80 %)* 81 (8 %)
Triglyceride, mmol/L 1.59 ± 0.94 1.60 ± 0.91
Total Cholesterol, mmol/L 4.62 ± 1.21* 5.22 ± 1.08
Low Density Lipoprotein, mmol/L 3.04 ± 1.66* 3.42 ± 1.00
High Density Lipoprotein, mmol/L 1.20 ± 0.52* 1.35 ± 0.34
Data were shown as mean ± standard deviation (SD) or as n (%). Significant
differences between cases and controls were indicated with an asterisk (*)
Table 2 Association between SNPs and ischemic stroke using the additive, genotype, dominant, and the recessive models
SNP Model Allele or geno case control Unadjusted




OR (95 % CI)
Adjusted
p-value
rs579459 Additive C/T 363/1455 334/1576 1.18 (1.00-1.39) 0.05 1.18 (0.97-1.43) 0.10
Dominant CC + CT/TT 326/583 300/655 1.22 (1.00-1.48) 0.04 1.20 (0.95-1.52) 0.12
Recessive CC/CT + TT 37/872 34/921 1.15 (0.71-1.85) 0.57 1.31 (0.74-2.31) 0.36
rs651007 Additive T/C 349/1421 337/1575 1.15 (0.97-1.36) 0.10 1.15 (0.94-1.40) 0.17
Dominant TT + CT/CC 314/571 304/652 1.18 (0.97-1.43) 0.09 1.16 (0.92-1.46) 0.22
Recessive TT/CT + CC 35/850 33/923 1.15 (0.71-1.87) 0.57 1.35 (0.76-2.40) 0.31
rs529565 Additive C/T 679/1087 709/1201 1.06 (0.93-1.21) 0.41 1.06 (0.90-1.24) 0.48
Dominant CC + CT/TT 540/343 565/390 1.09 (0.90-1.31) 0.38 1.08 (0.86-1.35) 0.52
Recessive CC/CT + TT 139/744 144/811 1.05 (0.82-1.36) 0.69 1.08 (0.79-1.47) 0.62
All SNPs were analyzed under additive, genotype, dominant (Dom) and recessive (Rec) models; OR: odds ratio; CI: confidence interval; unadjusted P-value from
t-test; adjusted P-value using logistic regression analysis with age, gender, hypertension, diabetes, and dyslipidemia as covariates. Significant P values (p < 0.05)
are in bold and p* < 0.017 (Bonferroni multiple correction threshold)
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significance after the Bonferroni adjustment for multiple
comparisons.
Comparison of allele and genotype frequencies in SVD
To explore whether the ABO polymorphisms are confined
to a specific subtype, we also evaluated the association
between the three SNPs of ABO gene and the risk of SVD.
As shown in Table 4, no significant associations were
observed for the allele and genotype frequencies between
the cases and controls in all three SNPs.
Discussion
The ABO gene is located near the end of the long arm of
chromosome 9 and encodes glycosyltransferases, which
add sugar residues to the H-antigen producing A or B
antigens of the ABO system. Previous studies found that
the non-O phenotypes were more frequent in ischemic
stroke patients than controls and was associated with an
increased risk of MI and CAD [18–20]. In consistent with
these results, previously study showed that compared with
the O phenotype, non-O phenotypes associated with an
increased risk of stroke [21]. In contrast, other study did
not detect significant association between ABO blood
group and ischemic stroke and any of the four main
etiologic subtypes of ischemic stroke [14]. Ischemic stroke
is a complex disease with different pathophysiology and
risk factors. It is important to investigate risk factors in
different etiologic subtypes. Some subtypes of ischemic
stroke and CAD shared many common risk factors, for
example, atherosclerosis plaque were observed in both
LAA and CAD as a common pathophysiologic mechan-
ism. Consequently, it was speculated that genetic variants
of ABO gene associated with CAD [12], may be also asso-
ciated with LAA.
Previous studies have found that polymorphisms of
ABO gene were associated with many diseases [12, 13, 15].
As reported previously that rs579459 in ABO gene was
associated with CAD in Caucasians [12]. Fewer studies
have investigated the genetic association between ABO
polymorphisms and ischemic stroke. Early studies
Table 3 Association between SNPs and LAA using the additive, genotype, dominant, and the recessive models
SNP Model Allele or geno case control Unadjusted




OR (95 % CI)
Adjusted
p-value
rs579459 Additive C/T 197/721 334/1576 1.29 (1.06-1.57) 0.01 1.27 (1.00-1.61) 0.047
Dominant CC + CT/TT 174/285 300/655 1.33 (1.06-1.68) 0.015 1.28 (0.96-1.70) 0.09
Recessive CC/CT + TT 23/436 34/921 1.43 (0.83-2.46) 0.19 1.70 (0.88-3.29) 0.11
rs651007 Additive T/C 193/703 337/1575 1.28 (1.05-1.56) 0.01 1.30 (1.02-1.64) 0.033
Dominant TT + CT/CC 170/278 304/652 1.31 (1.04-1.66) 0.02 1.29 (0.97-1.71) 0.08
Recessive TT/CT + CC 23/425 33/923 1.51 (0.88-2.61) 0.13 1.89 (0.97-3.65) 0.06
rs529565 Additive C/T 374/518 709/1201 1.22 (1.04-1.44) 0.01 1.24 (1.02-1.51) 0.03
Dominant CC + CT/TT 295/151 565/390 1.35 (1.07-1.71) 0.01 1.39 (1.05-1.84) 0.02
Recessive CC/CT + TT 79/367 144/811 1.21 (0.90-1.64) 0.21 1.24 (0.86-1.79) 0.25
All SNPs were analyzed under additive, genotype, dominant (Dom) and recessive (Rec) models; OR: odds ratio; CI: confidence interval; unadjusted P-value from
t-test; adjusted P-value using logistic regression analysis with age, gender, hypertension, diabetes, and dyslipidemia as covariates. Significant P values (p < 0.05)
are in bold and p* < 0.017 (Bonferroni multiple correction threshold)
Table 4 Association between SNPs and SVD using the additive, genotype, dominant, and the recessive models
SNP Model Allele or geno case control Unadjusted




OR (95 % CI)
Adjusted
p-value
rs579459 Additive C/T 166/734 334/1576 1.07 (0.87-1.31) 0.54 1.08 (0.85-1.39) 0.53
Dominant CC + CT/TT 152/298 300/655 1.11 (0.88-1.41) 0.38 1.10 (0.83-1.47) 0.51
Recessive CC/CT + TT 14/436 34/921 0.87 (0.46-1.64) 0.67 1.09 (0.51-2.32) 0.83
rs651007 Additive T/C 156/718 337/1575 1.02 (0.82-1.25) 0.89 1.03 (0.80-1.33) 0.80
Dominant TT + CT/CC 144/293 304/652 1.05 (0.83-1.34) 0.67 1.04 (0.78-1.39) 0.81
Recessive TT/CT + CC 12/425 33/923 0.79 (0.40-1.54) 0.49 1.05 (0.47-2.32) 0.91
rs529565 Additive C/T 305/569 709/1201 0.91 (0.77-1.07) 0.26 0.94 (0.77-1.14) 0.51
Dominant CC + CT/TT 245/192 565/390 0.88 (0.70-1.11) 0.28 0.87 (0.66-1.15) 0.33
Recessive CC/CT + TT 60/377 144/811 0.90 (0.65-1.24) 0.51 1.01 (0.69-1.50) 0.95
All SNPs were analyzed under additive, genotype, dominant (Dom) and recessive (Rec) models; OR: odds ratio; CI: confidence interval; unadjusted P-value from
t-test; adjusted P-value using logistic regression analysis with age, gender, hypertension, diabetes, and dyslipidemia as covariates. Significant P values (p < 0.05)
are in bold and p* < 0.017 (Bonferroni multiple correction threshold)
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reported that ABO gene variants (rs651007, rs643434, and
rs505922) are associated with LAA and cardioembolic
stroke in the European population [15]. However, there
was no study reported the association between ABO gene
and ischemic stroke in the Chinese population. Hence, in
our case–control study, we investigated the association of
four polymorphisms in ABO gene with the risk of ische-
mic stroke and its main subtypes. Our results supported
previous observations that ischemic stroke in particular
LAA and CAD share several risk factors. We found that
rs579459 in ABO gene was associated with LAA. In line
with previous study [15], our current study found signifi-
cant associations between ABO SNPs (rs651007 and
rs529565) and LAA, and these SNPs were failed to be
associated with ischemic stroke and SVD, although the
association disappeared after the Bonferroni adjustment,
which was known to be one of the most stringent
methods for multiple comparisons. The observed minimal
differences between the results from our results and previ-
ous study may partly due to differences in genetic back-
ground and our study have a small sample size.
Our study had a number of limitations. First, we
selected four SNPs of the ABO gene which showed
association with CAD or ischemic stroke in the
European population. These SNPs merely represented
limited genetic variability of ABO gene. The future
studies will be required to confirm the association
between ABO gene and ischemic stroke and its
subtypes by high density genotyping on SNPs of ABO
gene. Second, limited size of the cohort might reduce
the power to detect association. Thus, prospective inde-
pendent studies with a comparatively larger sample size
are required for validation in the Chinese population.
Conclusions
In the present study we aimed to investigate the associ-
ation between ABO gene and ischemic stroke and its main
subtypes in the Chinese population. We found that three
SNPs (rs651007, rs579459 and rs529565) of ABO gene
were significantly associated with LAA in the Chinese
population, though not survived Bonferroni correction for
multiple comparisons. Therefore, prospective studies with
a comparatively large sample size are required to confirm
the association between ABO gene and ischemic stroke in
the Chinese population and to characterize the functional
role of ABO underlying ischemic stroke or LAA.
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